Potassium chloride
Find information on thousands of medical conditions and prescription drugs.

Klor-con

The chemical compound potassium chloride (KCl) is a metal halide composed of potassium and chlorine. In its pure state it is odourless. It has a white to colourless vitreous crystal, with a face-centred cubic structure that cleaves easily in three directions. It is also commonly known as "Muriate of Potash". Potash varies in color from pink or red to white depending on the mining and recovery process used. White potash, sometimes referred to as soluble potash, is usually higher in analysis and is used primarily for making liquid starter fertilizers. more...

 Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
Clonazepam
K-Dur
Kadian
Kainic acid
Kanamycin
Kantrex
Kariva
Kayexalate
Keflex
Kefzol
Kemstro
Keppra
Ketalar
Ketamine
Ketanserin
Ketek
Ketoconazole
Ketoprofen
Ketorolac
Ketotifen
Kionex
Klor-con
Klotrix
Konazol
Korostatin
Kytril
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

KCl is used in medicine, scientific applications, food processing and in judicial execution through lethal injection. It occurs naturally as the mineral sylvite and in combination with sodium chloride as sylvinite.

Chemical properties

Potassium chloride can react as a source of chloride ion. As with any other soluble ionic chloride, it will precipitate insoluble chlorides when added to a solution of an appropriate metal salt such as silver nitrate:

KCl(aq) + Ag(NO3)(aq) → AgCl(s) + KNO3(aq)

Although potassium is more electropositive than sodium, KCl can be reduced to the metal by reaction with metallic sodium if the potassium is removed by distillation, due to Le Chatelier's principle:

Read more at Wikipedia.org
• [List your site here Free!]

Upsher-Smith Labs - Companies to Watch - plans to reach annual sales level of $250 million by end-2004 - Brief Article
From Drug Store News, 2/17/03

Minneapolis, (763) 473-4412 Upsher-Smith Laboratories plans on more than doubling its annual sales by the end of 2004. Acquisitions such as that of Rosemont Pharmaceutical Corp. two years ago will be just one piece of the puzzle in getting it to an annual sales level of $250 million.

Upsher-Smith hopes to hit those sales goals through strategic acquisitions and partnerships that will diversify the generic drug company's product portfolio. Since its acquisition of Rosemont, a Denverbased generic manufacturer with annual sales approaching $15 million, Upsher-smith has signed a $10 million licensing agreement to market Unigene Laboratories' patented nasal formulation of calcitonin for the treatment of osteoporosis in the United States.

Upsher-Smith also signed a licensing agreement for worldwide marketing rights of Novactyl's PCL-01 6 and FSR-488 formulations, two anti-viral agents currently being evaluated for the treatment of cold sores and genital herpes. PCL-016 was scheduled to enter Phase II human efficacy studies late last year.

The company currently markets six generic formulations under its Upsher-Smith brand name, including branded generic Pacerone (Amiodarone HCI) for treatment of recurrent life-threatening ventricular arrhythmias and Klor-Con, a branded prescriptiononly potassium chloride tablet.

COPYRIGHT 2003 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2003 Gale Group

Return to Klor-con
Home Contact Resources Exchange Links ebay